CLINICAL_TRIALS
trial_result
· 2023-11-02
Clinical Trial Update: A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight [Phase 2]
Summary
Phase 2 trial evaluating multiple doses of BI 456906 for weight loss in obesity has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2023-11-02